Period of time： 2013年3期
Publisher： Future Medicine
Founded in： 2006
Total resources： 64
ISSN： 1746-0794
Subject： R9 Pharmacy
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Future Virology,volume 2,issue 3
Menu
Topical microbicides against HIV spread: what, where and why?
By Singh Sunit Kumar in (2007)
Future Virology,volume 2,issue 3 , Vol. 2, Iss. 3, 2007-05 , pp.
Access to resources
Recommend
Rainy with a chance of plague: forecasting disease outbreaks from satellites
Future Virology,volume 2,issue 3 , Vol. 2, Iss. 3, 2007-05 , pp.Influenza defense: expanding our arsenal with peptide antivirals
By Jones Jeremy,Brandt Curtis R,Schultz-Cherry Stacey in (2007)
Future Virology,volume 2,issue 3 , Vol. 2, Iss. 3, 2007-05 , pp.Yellow striped caterpillar model used to test experimental influenza vaccine
Future Virology,volume 2,issue 3 , Vol. 2, Iss. 3, 2007-05 , pp.By Burgos Javier S,Valdivieso Fernando in (2007)
Future Virology,volume 2,issue 3 , Vol. 2, Iss. 3, 2007-05 , pp.Why is Kaposi’s sarcoma-associated herpesvirus not ubiquitous in the human population?
By Bagni Rachel,Whitby Denise in (2007)
Future Virology,volume 2,issue 3 , Vol. 2, Iss. 3, 2007-05 , pp.Murine polyomavirus virus-like particles as vectors for gene and immune therapy and as vaccines
By Ramqvist Torbjörn,Andreasson Kalle,Dalianis Tina in (2007)
Future Virology,volume 2,issue 3 , Vol. 2, Iss. 3, 2007-05 , pp.Immune responses to BK and JC viruses in immunocompromised patients
By Lacey Simon F,Zhou Wendi in (2007)
Future Virology,volume 2,issue 3 , Vol. 2, Iss. 3, 2007-05 , pp.Pathobiology of henipavirus entry: insights into therapeutic strategies
By Wolf Mike C,Negrete Oscar A,Lee Benhur in (2007)
Future Virology,volume 2,issue 3 , Vol. 2, Iss. 3, 2007-05 , pp.By Richer Martin J,Poffenberger Maya C,Horwitz Marc S in (2007)
Future Virology,volume 2,issue 3 , Vol. 2, Iss. 3, 2007-05 , pp.
Previous
Next